ABCL - AbCellera Biologics Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-76.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1054%)	96.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1104%)	788.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9752%)	37.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+370%)	133.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1566%)	-57.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-818%)	-45.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-662%)	-1.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-117%)	-27.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-440%)	-18.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-329%)	-57.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-817%)	-93.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1269%)	-78.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1076%)	-96.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1302%)	-84.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1157%)	1740.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+21658%)	66.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+726%)	56.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+602%)	-33.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-512%)	-41.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-615%)	146.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1727%)	4253.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+53068%)	—	—	—	—	—	—
EPS Growth YoY (%)	-50.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	6.7% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	72.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-11.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	7.7% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-7.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	35.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-70.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-18.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-70.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	-450.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	-100.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	37.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-57.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-300.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	5.4% Fair ↓ Fair Declining Year-over-year change in net income	5.4% Fair ↓ Fair Declining Year-over-year change in net income	73.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-12.3% Weak ↓ Weak Declining Year-over-year change in net income	-12.3% Weak ↓ Weak Declining Year-over-year change in net income	-12.3% Weak ↓ Weak Declining Year-over-year change in net income	27.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.2% Weak ↑ Weak Improving Year-over-year change in net income	-1.2% Weak ↑ Weak Improving Year-over-year change in net income	-1.2% Weak Weak Year-over-year change in net income	-57.7% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	N/M	43.8% Excellent ↑ Excellent Improving Year-over-year change in net income	43.8% Excellent ↑ Excellent Improving Year-over-year change in net income	43.8% Excellent Excellent Year-over-year change in net income	-48.8% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	—	—	—	—	—	—
FCF Growth YoY (%)	—	-65.3% Weak Weak Year-over-year change in free cash flow	—	—	—	66.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-9.6% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	-23.1% Weak Weak Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-26.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-12.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	27.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-55.5% Weak → Weak Stable Compound annual revenue growth over 3 years	-28.1% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-76.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-66.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	5.7% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	-35.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-63.4% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-64.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-3.6% Weak Weak Compound annual revenue growth over 3 years	37.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-31.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-47.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-26.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-0.9% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	8.8% Good Good Compound annual revenue growth over 5 years	-1.9% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	-63.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-525%)	—	-290.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2035%)	—	—	—	—	—	—	—	—	—	-175.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1269%)	37.2% Excellent → Excellent Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+148%)	-18.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-222%)	71.1% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+374%)	58.5% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+290%)	—	-25.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-270%)	78.0% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+420%)	77.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+416%)	-18.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-226%)	-7.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-151%)	-45.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-404%)	—	—
Effective Tax Rate (%) (%)	6.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	54.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.9% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	13.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	26.9% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.4% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	23.4% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	5.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	27.2% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.7% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.7% Good → Good Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	42.9% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	27.0% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	29.2% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	14.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-12.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	27.4% Caution Caution Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-19.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-266%)	—	-267.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2325%)	—	—	—	—	-408.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3500%)	—	—	-398.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3424%)	-329.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2842%)	-138.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1256%)	—	—	53.2% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+344%)	43.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+259%)	—	—	57.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+382%)	56.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+369%)	-22.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-286%)	-18.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-255%)	-44.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-475%)	—	—
FCF Margin (%) (%)	—	-449.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-99.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-467.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-370.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-484.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	86.2% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	27.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-18.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	52.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-82.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	198.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-28.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	-0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	4.98x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.35x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.62x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.47x Good Good Free cash flow relative to reported net income Optimal: > 1x	-0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.00x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	3.67x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-10.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-6.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.6% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	5.6% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	12.0% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	15.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-4.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-3.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	2.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	14.1% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	—	-2.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	14.0% Good Good Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-4.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-106%)	-4.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-3.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-3.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-3.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	-3.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-122%)	-2.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	13.5% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-10%)	13.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	14.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	5.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	12.3% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	12.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-19%)	12.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	14.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-6%)	-2.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-116%)	-2.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	-2.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-120.06M	$-77.06M	$-128.51M	$-83.16M	$-92.44M	$-159.27M	$-156.32M	$-126.64M	$-148.31M	$-123.57M	—	$-172.42M	$-179.75M	$-193.02M	—	$-371.97M	$-790.62M	$-545.72M	—	$-517.69M	$-792.57M	$-685.79M	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.01	$0.03	—	$0.03	$0.06	$0.01	—	$0.02	$0.02	$0.03	—	$0.02	$0.03	$0.04	—	$0.36	$0.16	$1.12	—	$0.02	$0.10	$0.75	—	$0.06	$0.07	$0.03	—	—
Basic EPS, GAAP (USD)	$-0.18	$-0.14	$-0.03	$-0.19	$-0.12	$-0.15	$-0.11	$-0.17	$-0.13	$-0.14	$-0.17	$-0.10	$-0.11	$-0.14	$-0.10	$0.09	$-0.02	$0.59	$0.22	$-0.08	$-0.01	$0.43	$0.52	$-0.02	$0.03	$-0.01	—	—
Free Cash Flow per Share (USD)	$0.08	$-0.12	—	$-0.21	—	$-0.07	—	—	—	$-0.22	—	—	—	$-0.21	—	—	—	$0.30	—	—	—	$0.39	—	$-0.05	$0.15	$-0.01	—	—
Book Value per Share (USD)	$2.92	$3.09	$3.22	$3.22	$3.41	$3.46	$3.57	$3.71	$3.82	$3.89	—	$4.12	$4.17	$4.21	—	$4.37	$4.25	$4.24	—	$3.39	$3.49	$3.53	—	$0.58	$0.60	$0.55	—	—
Tangible Book Value per Share (USD)	$2.65	$2.81	$2.93	$2.93	$3.11	$3.16	$3.27	$3.36	$3.36	$3.31	—	$3.52	$3.56	$3.60	—	$3.71	$3.58	$3.56	—	$2.69	$2.98	$3.00	—	$0.58	$0.60	$0.55	—	—
Basic Weighted Avg Shares (shares)	305.56M	303.07M	—	298.88M	298.51M	297.69M	—	294.85M	294.22M	292.72M	—	289.50M	288.91M	287.77M	—	285.32M	284.69M	283.90M	—	278.93M	272.20M	269.70M	—	153.05M	152.33M	151.86M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$626.04M	$617.30M	$663.92M	$626.34M	$675.12M	$689.58M	$674.76M	$663.32M	$701.17M	$709.07M	—	$809.28M	$811.83M	$851.06M	—	$939.62M	$922.82M	$960.96M	—	$754.20M	$794.24M	$819.59M	—	—	—	—	—	—
Total Equity (USD)	$896.02M	$938.08M	$966.90M	$964.04M	$1.01B	$1.02B	$1.06B	$1.08B	$1.11B	$1.13B	$1.15B	$1.18B	$1.19B	$1.21B	$1.23B	$1.25B	$1.21B	$1.21B	$1.03B	$953.40M	$967.68M	$957.12M	$830.51M	$89.26M	$90.89M	$83.69M	$10.25M	$11.61M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$4.05M	$8.31M	$44.85M	$8.96M	$17.08M	$4.24M	$5.05M	$6.51M	$7.32M	$9.95M	$9.18M	$6.60M	$10.06M	$12.19M	$21.55M	$101.38M	$45.92M	$316.58M	$139.33M	$5.51M	$27.64M	$202.74M	$207.91M	$9.36M	$11.23M	$4.66M	—	—
Depreciation Expense (USD)	$6.99M	$6.84M	$5.18M	$4.30M	$4.50M	$4.41M	$2.10M	$3.80M	$3.40M	$3.15M	$3.88M	$3.10M	$3.00M	$2.86M	$2.74M	$2.50M	$2.30M	$1.39M	$1.34M	$1.20M	$1.10M	$840.00K	$810.00K	$0.00	$1.10M	$415.00K	—	—
Net Income, GAAP (USD)	$-43.16M	$-43.16M	$-8.95M	$-45.62M	$-45.62M	$-45.62M	$-34.21M	$-40.61M	$-40.61M	$-40.61M	$-47.15M	$-40.11M	$-40.11M	$-40.11M	$-29.89M	$168.57M	$168.57M	$168.57M	$59.95M	$117.22M	$117.22M	$117.22M	$117.00M	$-2.09M	$-2.09M	$-2.09M	—	—
Operating Cash Flow (USD)	$25.92M	$-33.52M	$-34.74M	$-52.59M	—	$-11.55M	$-8.00M	—	—	$-41.71M	$-19.61M	—	—	$-44.06M	$30.91M	—	—	$100.22M	$-16.71M	—	—	$109.55M	$1.28M	$-3.80M	$25.98M	$-764.00K	—	—

AbCellera Biologics Inc.

Analytical Summary

28-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ABCL with peers